After four weeks of destabilization of the medial meniscus surgery to establish an osteoarthritis model, the rats received weekly articular cavity injection of SMSCs with or without GW4869 treatment or exosomes from SMSCs with or without microRNA-320c overexpression for another four weeks.
[Inflammopharmacology]